Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications

Chitra Viswanathan, Kimberly Kirschner, Mylene Truong, Aparna Balachandran, Catherine Devine, Priya Bhosale

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE. Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women. Survival depends on the lymph node status. Lymph node-negative patients have a 5-year survival of 90%, whereas survival drops to about 50% in patients with positive lymph nodes. The purpose of this article is to familiarize the reader with the revised International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer and incorporate it into daily practice when interpreting cross-sectional imaging studies. CONCLUSION. Although vulvar cancer is diagnosed clinically, cross-sectional imaging plays an important complimentary role in staging of the tumor, assessing extent of disease, and selecting operable versus inoperable candidates to ultimately help in decreasing morbidity and increasing survival in these patients.

Original languageEnglish
Pages (from-to)1387-1400
Number of pages14
JournalAmerican Journal of Roentgenology
Volume200
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Vulvar Neoplasms
Neoplasm Staging
Survival
Lymph Nodes
Therapeutics
Gynecology
Obstetrics
Cross-Sectional Studies
Morbidity
Carcinoma
Neoplasms

Keywords

  • Complications
  • International Federation of Gynecology and Obstetrics (FIGO)
  • MRI
  • PET/CT
  • Vulvar cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Viswanathan, C., Kirschner, K., Truong, M., Balachandran, A., Devine, C., & Bhosale, P. (2013). Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications. American Journal of Roentgenology, 200(6), 1387-1400. https://doi.org/10.2214/AJR.12.9714

Multimodality imaging of vulvar cancer : Staging, therapeutic response, and complications. / Viswanathan, Chitra; Kirschner, Kimberly; Truong, Mylene; Balachandran, Aparna; Devine, Catherine; Bhosale, Priya.

In: American Journal of Roentgenology, Vol. 200, No. 6, 06.2013, p. 1387-1400.

Research output: Contribution to journalArticle

Viswanathan, C, Kirschner, K, Truong, M, Balachandran, A, Devine, C & Bhosale, P 2013, 'Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications', American Journal of Roentgenology, vol. 200, no. 6, pp. 1387-1400. https://doi.org/10.2214/AJR.12.9714
Viswanathan C, Kirschner K, Truong M, Balachandran A, Devine C, Bhosale P. Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications. American Journal of Roentgenology. 2013 Jun;200(6):1387-1400. https://doi.org/10.2214/AJR.12.9714
Viswanathan, Chitra ; Kirschner, Kimberly ; Truong, Mylene ; Balachandran, Aparna ; Devine, Catherine ; Bhosale, Priya. / Multimodality imaging of vulvar cancer : Staging, therapeutic response, and complications. In: American Journal of Roentgenology. 2013 ; Vol. 200, No. 6. pp. 1387-1400.
@article{1cd441331d33494f997f4d7a67596cbe,
title = "Multimodality imaging of vulvar cancer: Staging, therapeutic response, and complications",
abstract = "OBJECTIVE. Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women. Survival depends on the lymph node status. Lymph node-negative patients have a 5-year survival of 90{\%}, whereas survival drops to about 50{\%} in patients with positive lymph nodes. The purpose of this article is to familiarize the reader with the revised International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer and incorporate it into daily practice when interpreting cross-sectional imaging studies. CONCLUSION. Although vulvar cancer is diagnosed clinically, cross-sectional imaging plays an important complimentary role in staging of the tumor, assessing extent of disease, and selecting operable versus inoperable candidates to ultimately help in decreasing morbidity and increasing survival in these patients.",
keywords = "Complications, International Federation of Gynecology and Obstetrics (FIGO), MRI, PET/CT, Vulvar cancer",
author = "Chitra Viswanathan and Kimberly Kirschner and Mylene Truong and Aparna Balachandran and Catherine Devine and Priya Bhosale",
year = "2013",
month = "6",
doi = "10.2214/AJR.12.9714",
language = "English",
volume = "200",
pages = "1387--1400",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - Multimodality imaging of vulvar cancer

T2 - Staging, therapeutic response, and complications

AU - Viswanathan, Chitra

AU - Kirschner, Kimberly

AU - Truong, Mylene

AU - Balachandran, Aparna

AU - Devine, Catherine

AU - Bhosale, Priya

PY - 2013/6

Y1 - 2013/6

N2 - OBJECTIVE. Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women. Survival depends on the lymph node status. Lymph node-negative patients have a 5-year survival of 90%, whereas survival drops to about 50% in patients with positive lymph nodes. The purpose of this article is to familiarize the reader with the revised International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer and incorporate it into daily practice when interpreting cross-sectional imaging studies. CONCLUSION. Although vulvar cancer is diagnosed clinically, cross-sectional imaging plays an important complimentary role in staging of the tumor, assessing extent of disease, and selecting operable versus inoperable candidates to ultimately help in decreasing morbidity and increasing survival in these patients.

AB - OBJECTIVE. Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women. Survival depends on the lymph node status. Lymph node-negative patients have a 5-year survival of 90%, whereas survival drops to about 50% in patients with positive lymph nodes. The purpose of this article is to familiarize the reader with the revised International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer and incorporate it into daily practice when interpreting cross-sectional imaging studies. CONCLUSION. Although vulvar cancer is diagnosed clinically, cross-sectional imaging plays an important complimentary role in staging of the tumor, assessing extent of disease, and selecting operable versus inoperable candidates to ultimately help in decreasing morbidity and increasing survival in these patients.

KW - Complications

KW - International Federation of Gynecology and Obstetrics (FIGO)

KW - MRI

KW - PET/CT

KW - Vulvar cancer

UR - http://www.scopus.com/inward/record.url?scp=84880958730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880958730&partnerID=8YFLogxK

U2 - 10.2214/AJR.12.9714

DO - 10.2214/AJR.12.9714

M3 - Article

C2 - 23701080

AN - SCOPUS:84880958730

VL - 200

SP - 1387

EP - 1400

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 6

ER -